High-priority veterinary and pharmaceutical essentials optimized for the Kazakh livestock and medical sectors.
Kazakhstan stands as a pivotal hub in Central Asia, undergoing a massive transformation under the "Kazakhstan 2050 Strategy". The nation is aggressively moving towards reducing its reliance on pharmaceutical imports by fostering international partnerships and localizing high-tech production. As a landlocked powerhouse, Kazakhstan serves as a gateway to the Eurasian Economic Union (EAEU).
The demand for veterinary medicine is particularly high, driven by the vast livestock resources (cattle, sheep, and horses) that form the backbone of the Kazakh rural economy. Our presence in this market focuses on bringing GMP-certified Chinese pharmaceutical innovations to meet the rigorous quality standards demanded by the Ministry of Health and the Ministry of Agriculture of the Republic of Kazakhstan.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Leveraging AI-driven manufacturing and bio-fermentation for superior product efficacy.
Utilizing micro-encapsulation technology to ensure homogeneous distribution of active ingredients in livestock feed, specifically formulated for the diverse climatic conditions of Central Asia.
Enhancing the solubility and stability of poorly water-soluble APIs, ensuring maximum bioavailability and shelf-life even in extreme temperature fluctuations typical of the Kazakh steppe.
Advanced microbial fermentation processes for high-purity vitamins and amino acids, ensuring natural and sustainable growth performance for the modern agricultural sector.
While the pharmaceutical world shifts toward Personalized Medicine and Biological Therapeutics, Serum Pharma bridges the gap between global innovation and local application in Kazakhstan. Our products are not just commodities; they are integrated solutions for health stability.
Stay ahead with the latest breakthroughs in global and regional pharmacology.
Deep dive into the rising demand for natural vaccine adjuvants in the CIS region and the shift away from shark-based squalene.
Why this critical molecule remains a cornerstone for respiratory treatments in high-altitude regions like Eastern Kazakhstan.
Analyzing the breakthrough of orforglipron and its implications for metabolic health management in urban Kazakh populations.
Extending our specialized range to cover nutrition, anti-infectives, and pain management.
By 2030, Serum Pharma aims to integrate AI-driven diagnostic tools with our pharmaceutical supply in Kazakhstan. This involves:
